Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ben, van den Borne"'
Autor:
Esther Visser, Remco de Kock, Sylvia Genet, Ben van den Borne, Maggy Youssef-El Soud, Huub Belderbos, Gerben Stege, Marleen de Saegher, Susan van ’t Westeinde, Maarten Broeren, Federica Eduati, Birgit Deiman, Volkher Scharnhorst
Publikováno v:
Translational Oncology, Vol 27, Iss , Pp 101589- (2023)
Identification of actionable mutations in advanced stage non-squamous non-small-cell lung cancer (NSCLC) patients is recommended by guidelines as it enables treatment with targeted therapies. In current practice, mutations are identified by next-gene
Externí odkaz:
https://doaj.org/article/79ac771ec13d4069bc3b639652b73652
Autor:
Simon A. Keek, Esma Kayan, Avishek Chatterjee, José S. A. Belderbos, Gerben Bootsma, Ben van den Borne, Anne-Marie C. Dingemans, Hester A. Gietema, Harry J. M. Groen, Judith Herder, Cordula Pitz, John Praag, Dirk De Ruysscher, Janna Schoenmaekers, Hans J. M. Smit, Jos Stigt, Marcel Westenend, Haiyan Zeng, Henry C. Woodruff, Philippe Lambin, Lizza Hendriks
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: Despite radical intent therapy for patients with stage III non-small-cell lung cancer (NSCLC), cumulative incidence of brain metastases (BM) reaches 30%. Current risk stratification methods fail to accurately identify these patients. As
Externí odkaz:
https://doaj.org/article/9a92cc6300fc4c7c9959e69e2b3229ec
Autor:
Remco de Kock, Ben van den Borne, Maggy Youssef- El Soud, Huub Belderbos, Gerben Stege, Marleen de Saegher, Claartje van Dongen-Schrover, Sylvia Genet, Luc Brunsveld, Volkher Scharnhorst, Birgit Deiman, PhD
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100410- (2021)
Liquid biopsies have become of interest as minimally invasive ways to monitor treatment response in lung cancer patients. Circulating tumor DNA (ctDNA) and protein biomarkers are evaluated for their added value in monitoring therapy response and earl
Externí odkaz:
https://doaj.org/article/5c3bbed9ec4e42fb846a0147a210c21b
Autor:
Remco de Kock, Chantal Knoops, Mieke Baselmans, Ben van den Borne, Luc Brunsveld, Volkher Scharnhorst, Birgit Deiman
Publikováno v:
Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100449- (2021)
Supernatant pleural effusions (PE) have shown to be a valuable source for the detection of driver mutations in circulating tumor DNA (ctDNA). In this prospective study, the clinical value of ctDNA analysis in supernatant PE to support therapy selecti
Externí odkaz:
https://doaj.org/article/7a8d7abe97424d11a119332d88bf4042
Autor:
Sharina Kort, Marjolein Brusse-Keizer, Hugo Schouwink, Emanuel Citgez, Frans H. de Jongh, Jan W.G. van Putten, Ben van den Borne, Elisabeth A. Kastelijn, Daiana Stolz, Milou Schuurbiers, Michel M. van den Heuvel, Wouter H. van Geffen, Job van der Palen
Publikováno v:
Chest, 163, 3, pp. 697-706
Chest, 163, 697-706
Chest, 163, 697-706
Item does not contain fulltext
Autor:
Janneke van Roij, Natasja Raijmakers, Laurien Ham, Marieke van den Beuken-van Everdingen, Ben van den Borne, Geert-Jan Creemers, Jarmo Cornelis Hunting, Evelien Kuip, Lobke van Leeuwen, Hanneke van Laarhoven, Caroline Mandigers, Peter Nieboer, Lilly-Ann van der Velden, Lia van Zuylen, John Gelissen, Myrte Zijlstra, Linda Brom, Heidi P. Fransen, Lonneke van de Poll-Franse
Publikováno v:
the eQuiPe study group 2022, ' Quality of life and quality of care as experienced by patients with advanced cancer and their relatives : A multicentre observational cohort study (eQuiPe) ', European Journal of Cancer, vol. 165, pp. 125-135 . https://doi.org/10.1016/j.ejca.2022.01.039
European Journal of Cancer, 165, 125-135
European Journal of Cancer, 165, 125-135. Elsevier Ltd.
European Journal of Cancer, 165, pp. 125-135
European Journal of Cancer, 165, 125-135. ELSEVIER SCI LTD
European Journal of Cancer, 165, 125-135. Elsevier Limited
European Journal of Cancer, 165, 125-135. Pergamon
European Journal of Cancer, 165, 125-135
European Journal of Cancer, 165, 125-135. Elsevier Ltd.
European Journal of Cancer, 165, pp. 125-135
European Journal of Cancer, 165, 125-135. ELSEVIER SCI LTD
European Journal of Cancer, 165, 125-135. Elsevier Limited
European Journal of Cancer, 165, 125-135. Pergamon
AIM: This study aims to assess the quality of life and quality of care as experienced by patients with advanced cancer and their relatives while taking their interdependency into account.METHODS: A prospective multicentre observational study (eQuiPe
Autor:
Laurien Ham, Heidi P. Fransen, Janneke van Roij, Ben van den Borne, Geert Jan Creemers, Mathijs P. Hendriks, Evelien Kuip, Hanneke W. M. van Laarhoven, Lobke van Leeuwen, Annemieke van der Padt‐Pruijsten, Tineke Smilde, Margriet Stellingwerf, Lia van Zuylen, Lonneke van de Poll‐Franse, Natasja J. H. Raijmakers
Publikováno v:
Ham, L, Fransen, H P, van Roij, J, van den Borne, B, Creemers, G J, Hendriks, M P, Kuip, E, van Laarhoven, H W M, van Leeuwen, L, van der Padt-Pruijsten, A, Smilde, T, Stellingwerf, M, van Zuylen, L, van de Poll-Franse, L & Raijmakers, N J H 2022, ' Emotional functioning during bereavement after the death of patients with advanced cancer and associated factors ', Psycho-Oncology, vol. 31, no. 10, pp. 1719-1727 . https://doi.org/10.1002/pon.6031
Psycho-oncology, 31(10), 1719-1727. John Wiley and Sons Ltd
Psycho-Oncology, 31(10), 1719-1727. John Wiley and Sons Ltd
Psycho-Oncology, 31, 10, pp. 1719-1727
Psycho-Oncology, 31, 1719-1727
Psycho-Oncology, 31(10), 1719-1727. Wiley
Psycho-oncology, 31(10), 1719-1727. John Wiley and Sons Ltd
Psycho-Oncology, 31(10), 1719-1727. John Wiley and Sons Ltd
Psycho-Oncology, 31, 10, pp. 1719-1727
Psycho-Oncology, 31, 1719-1727
Psycho-Oncology, 31(10), 1719-1727. Wiley
ObjectiveThe death of a loved one is considered to be the most stressful of all life events. However, the impact of bereavement on quality of life varies between individuals. The aim of our study was to assess emotional functioning (EF), which is a d
Autor:
Savvas Paschos, Nora Lize, Simone Eussen, Annemieke van der Padt-Pruijsten, Marieke van den Beuken-van Everdingen, Hanneke van Laarhoven, Marien den Boer, Alexander de Graeff, Ben van den Borne, Herma ten Have, Marjolanda Kennis, Sandra Beijer, Natasja J. H. Raijmakers, Lonneke van de Poll-Franse
Publikováno v:
Supportive care in cancer, 31(3):189. Springer Verlag
Supportive Care in Cancer, 31(3):189. Springer Verlag
Paschos, S, Lize, N, Eussen, S, van der Padt-Pruijsten, A, van den Beuken-van Everdingen, M, van Laarhoven, H, den Boer, M, de Graeff, A, van den Borne, B, ten Have, H, Kennis, M, Beijer, S, Raijmakers, N J H & van de Poll-Franse, L 2023, ' Are gastrointestinal problems, nutritional care, and nutritional care needs associated with quality of life in patients with advanced cancer? Results of the observational eQuiPe study ', Supportive Care in Cancer, vol. 31, no. 3, 189 . https://doi.org/10.1007/s00520-023-07646-1
Supportive Care in Cancer, 31(3):189. Springer, Cham
Supportive Care in Cancer, 31(3):189. Springer Verlag
Paschos, S, Lize, N, Eussen, S, van der Padt-Pruijsten, A, van den Beuken-van Everdingen, M, van Laarhoven, H, den Boer, M, de Graeff, A, van den Borne, B, ten Have, H, Kennis, M, Beijer, S, Raijmakers, N J H & van de Poll-Franse, L 2023, ' Are gastrointestinal problems, nutritional care, and nutritional care needs associated with quality of life in patients with advanced cancer? Results of the observational eQuiPe study ', Supportive Care in Cancer, vol. 31, no. 3, 189 . https://doi.org/10.1007/s00520-023-07646-1
Supportive Care in Cancer, 31(3):189. Springer, Cham
Purpose: To assess the association of gastrointestinal problems, received nutritional care, and nutritional care needs with quality of life (QoL) in patients with advanced cancer. Methods: A cross-sectional analysis within the observational prospecti
Autor:
Esther Visser, Remco de Kock, Sylvia Genet, Ben van den Borne, Maggy Youssef-El Soud, Huub Belderbos, Gerben Stege, Marleen de Saegher, Susan van ’t Westeinde, Maarten Broeren, Federica Eduati, Birgit Deiman, Volkher Scharnhorst
Publikováno v:
Translational Oncology, 27:101589. Neoplasia Press
Identification of actionable mutations in advanced stage non-squamous non-small-cell lung cancer (NSCLC) patients is recommended by guidelines as it enables treatment with targeted therapies. In current practice, mutations are identified by next-gene
Autor:
Sharina, Kort, Marjolein, Brusse-Keizer, Hugo, Schouwink, Emanuel, Citgez, Frans, de Jongh, John, van Putten, Ben, van den Borne, Lisanne, Kastelijn, Daiana, Stolz, Milou, Schuurbiers, Michel, van den Heuvel, Wouter H, van Geffen, Job, van der Palen
Publikováno v:
Chest.
Despite the potential of exhaled breath analysis of volatile organic compounds to diagnose lung cancer, clinical implementation has not been realized, partly due to the lack of validation studies.This study addressed two questions. First, can we simu